Medicare Enrolled

Dr. Stephen Yandel, DO

Hematology · Titusville, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
845 CENTURY MEDICAL DR STE B, Titusville, FL 32796
3215296202
Registered in NPPES since 2006
NPI: 1952366619 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yandel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yandel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yandel

Dr. Stephen Yandel is a hematology specialist in Titusville, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Yandel performed 899 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Yandel received a total of $6,914 from 59 pharmaceutical and/or device companies across 331 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yandel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 899 Medicare services $6,914 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
899
Medicare services
Bottom 21% in FL for hematology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
456 $40 $114
Initial hospital admission, low complexity
Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter.
129 $66 $220
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
110 $100 $292
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
109 $62 $157
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
27 $94 $260
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
23 $110 $217
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
23 $137 $420
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
22 $72 $148
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,914
Total received (2019-2024)
Avg $1,152/year across 6 years
Bottom 49% in FL for hematology
59
Companies
331
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$747
2023
$162
2022
$1,857
2021
$2,790
2020
$1,000
2019
$360

Payments by company (2024)

PFIZER INC.
$192
AstraZeneca Pharmaceuticals LP
$100
JAZZ PHARMACEUTICALS INC.
$47
Janssen Biotech, Inc.
$42
RECORDATI_RARE_DISEASES_INC.
$41
Daiichi Sankyo Inc.
$39
Incyte Corporation
$36
Merck Sharp & Dohme LLC
$23
Aveo Pharmaceuticals, Inc.
$23
Eisai Inc.
$22
GE HEALTHCARE
$20
Bayer Healthcare Pharmaceuticals Inc.
$20
MorphoSys, US Inc.
$19
Blueprint Medicines Corporation
$19
Celgene Corporation
$17
ABBVIE INC.
$16
Deciphera Pharmaceuticals Inc.
$16
E.R. Squibb & Sons, L.L.C.
$15
Lilly USA, LLC
$14
Novartis Pharmaceuticals Corporation
$13
Regeneron Healthcare Solutions, Inc.
$13
Top 3 companies account for 45.4% of 2024 payments
All-time payments by company (2019-2024) ›
Novartis Pharmaceuticals Corporation
$1,260
PFIZER INC.
$729
AstraZeneca Pharmaceuticals LP
$591
Daiichi Sankyo Inc.
$543
Merck Sharp & Dohme Corporation
$391
Seagen Inc.
$360
GENZYME CORPORATION
$292
E.R. Squibb & Sons, L.L.C.
$189
Janssen Biotech, Inc.
$173
BeiGene USA, Inc.
$150
JAZZ PHARMACEUTICALS INC.
$134
AbbVie Inc.
$129
Astellas Pharma US Inc
$124
Boehringer Ingelheim Pharmaceuticals, Inc.
$116
Celgene Corporation
$114
Janssen Pharmaceuticals, Inc
$112
Merck Sharp & Dohme LLC
$108
Global Blood Therapeutics, Inc.
$101
Lilly USA, LLC
$88
Incyte Corporation
$78
Bayer HealthCare Pharmaceuticals Inc.
$73
Sobi, Inc
$70
Pharmacosmos Therapeutics Inc.
$64
PUMA BIOTECHNOLOGY, INC.
$61
MorphoSys, US Inc.
$60
Servier Pharmaceuticals LLC
$50
Organon LLC
$47
EISAI INC.
$47
Eisai Inc.
$46
RECORDATI_RARE_DISEASES_INC.
$41
Genentech USA, Inc.
$34
Kite Pharma, Inc.
$31
Regeneron Healthcare Solutions, Inc.
$28
ARRAY BIOPHARMA INC
$28
Agios Pharmaceuticals, Inc.
$24
Aveo Pharmaceuticals, Inc.
$23
G1 Therapeutics, Inc.
$22
Myriad Genetic Laboratories, Inc.
$21
Heron Therapeutics, Inc.
$21
GE HEALTHCARE
$20
TOLMAR Pharmaceuticals, Inc.
$20
Bayer Healthcare Pharmaceuticals Inc.
$20
Coherus Biosciences Inc.
$20
Progenics Pharmaceuticals, Inc.
$19
Blueprint Medicines Corporation
$19
ADC Therapeutics America, Inc.
$19
Dendreon Pharmaceuticals LLC
$19
West Therapeutics Development, LLC
$17
Myovant Sciences Inc.
$17
ABBVIE INC.
$16
Deciphera Pharmaceuticals Inc.
$16
GlaxoSmithKline, LLC.
$16
GRT US Holding, Inc.
$16
Taiho Oncology, Inc.
$16
Emmaus Medical, Inc.
$15
MAYNE PHARMA INC.
$15
Jazz Pharmaceuticals Inc.
$14
EKOS Corporation
$14
Amgen Inc.
$11
Top 3 companies account for 37.3% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AYVAKIT · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CALQUENCE · CINVANTI · COSELA · CYRAMZA · DARZALEX · DOPTELET · EKOSONIC · ELAHERE · ELIGARD · ELITEK · ENHERTU · ENJAYMO · ERLEADA · Endari · Enhertu · FOTIVDA · GAZYVA · GILOTRIF · IBRANCE · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INQOVI · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kadcyla · LENVIMA · LIBTAYO · LUTATHERA · LYNPARZA · Lazanda · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · Monoferric · NERLYNX · Nplate · Nubeqa · ONTRUZANT · ONUREG · OPDIVO · ORGOVYX · OXBRYTA · PADCEV · PIQRAY · PROMACTA · PROVENGE · PYLARIFY · PYRUKYND · Pomalyst · QINLOCK · Qutenza · REBLOZYL · REMICADE · RYBREVANT · Revlimid · SARCLISA · SCEMBLIX · SYLVANT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TECVAYLI · TIBSOVO · TUKYSA · Udenyca · VENCLEXTA · VERZENIO · XALKORI · XARELTO · XTANDI · ZEPZELCA · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology specialist in Titusville?
Compare hematologists in the Titusville area by procedure volume, costs, and industry payment transparency.
Browse hematologists nearby

Geographic Context

Hematologists in nearby ZIP areas
4
County median income
$75,817
Nearest hospital to ZIP centroid (approximate)
PARRISH MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Yandel is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Yandel experienced with hospital follow-up visit, low complexity?
Based on Medicare claims data, Dr. Yandel performed 456 hospital follow-up visit, low complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Yandel receive payments from pharmaceutical companies?
Yes. Dr. Yandel received a total of $6,914 from 59 companies across 331 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yandel's costs compare to other hematologists in Titusville?
Dr. Yandel's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yandel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →